Increased 18F-FAPI Uptake in Radiation-Induced Liver Injury.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 Oct 2023
01 Oct 2023
Historique:
medline:
11
9
2023
pubmed:
8
9
2023
entrez:
8
9
2023
Statut:
ppublish
Résumé
A 51-year-old woman with breast cancer underwent a complete surgical resection and chemoradiotherapy approximately 3 months ago. Follow-up abdominal ultrasound detected a new lesion with decreased echogenicity in the hepatic segment IV/VIII. 18F-FDG PET/CT showed the hepatic lesion without abnormal uptake. The patient was subsequently enrolled in a clinical trial of 18F-FAPI PET/CT to assess the hepatic lesion. An intense 18F-FAPI activity was identified in the hepatic lesion. Finally, pathological analysis combined with imaging follow-up confirmed the diagnosis of radiation-induced liver injury.
Identifiants
pubmed: 37682614
doi: 10.1097/RLU.0000000000004801
pii: 00003072-202310000-00027
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e474-e476Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared. This study was supported by the National Natural Science Foundation of China (no. 82101994) and the Affiliated Cancer Hospital and Institute of Guangzhou Medical University Clinical Research 5555 Program (no. IIT-2022-015[HYX]).
Références
Kim J, Jung Y. Radiation-induced liver disease: current understanding and future perspectives. Exp Mol Med . 2017;49:e359.
Du S, Chen G, Yuan B, et al. DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury. Cell Mol Immunol . 2021;18:1718–1728.
Rabe TM, Yokoo T, Meyer J, et al. Radiation-induced liver injury mimicking metastatic disease in a patient with esophageal cancer: correlation of positron emission tomography/computed tomography with magnetic resonance imaging and literature review. J Comput Assist Tomogr . 2016;40:560–563.
Voncken FEM, Aleman BMP, van Dieren JM, et al. Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer: a retrospective study and literature review. Strahlenther Onkol . 2018;194:156–163.
Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol . 2011;25:195–206.
Çermik TF, Ergül N, Yılmaz B, et al. Tumor imaging with 68 Ga-DOTA-FAPI-04 PET/CT: comparison with 18 F-FDG PET/CT in 22 different cancer types. Clin Nucl Med . 2022;47:e333–e339.
Zhang J, He Q, Jiang S, et al. [ 18 F]FAPI PET/CT in the evaluation of focal liver lesions with [ 18 F]FDG non-avidity. Eur J Nucl Med Mol Imaging . 2023;50:937–950.
Zhao L, Gu J, Fu K, et al. 68 Ga-FAPI PET/CT in assessment of liver nodules in a cirrhotic patient. Clin Nucl Med . 2020;45:e430–e432.
Deng Y, Wu J, Xu C, et al. Primary solitary tuberculosis in the hepatic round ligament detected by 68 Ga-FAPI PET/CT. Clin Nucl Med . 2022;47:e414–e416.
Ergul N, Yilmaz B, Cin M, et al. 68 Ga-DOTA-FAPI-04 PET/CT in neuroendocrine carcinoma of the liver with elevated AFP level: comparison with 18 F-FDG PET/CT. Clin Nucl Med . 2022;47:e29–e31.
Kou Y, Yao Z, Cheng Z. Hepatic lesion of mucosa-associated lymphoid tissue lymphoma revealed by Al 18 F-NOTA-FAPI-04 PET/CT. Clin Nucl Med . 2022;47:e49–e51.
Chen Z, Xue Q, Yang Y, et al. 68 Ga-FAPI and 18 F-FDG PET/CT images of a patient with Rosai-Dorfman disease with liver involvement. Clin Nucl Med . 2022;47:1079–1081.